Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Julie Larson-green is Director at Health Catalyst. OQRO lists 6 transactions filed with the SEC under this name, the latest on Sep 4, 2026, each linked to the official Form 4.
Director
Disclosures on record
6
Companies involved
1
As of the latest filing on , Julie Larson-green reported holding 185,101 shares of Health Catalyst (HCAT), worth about $280K at the last close of $2 (Nov 13, 2026). In the last 12 months, Julie Larson-green sold $128K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Health Catalyst HCAT | 185,101 | 185K direct | $2 | $280K | Sep 1, 2026 |
Is this Julie Larson-green’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Health CatalystHCAT
6 disclosures · Dec 2025 – Sep 2026 · 1 sold
Sep 1, 20269,766disclosed Sep 4
DetailsOfficial recordJul 16, 202681Kdisclosed Jul 21
DetailsOfficial recordJun 1, 202613Kdisclosed Jun 4
DetailsOfficial recordMar 1, 20268,361disclosed Mar 6
DetailsOfficial recordDec 4, 2025Sold~$128Kdisclosed Dec 10
DetailsOfficial recordDec 1, 20255,731disclosed Dec 4
DetailsOfficial recordJulie Larson-green has no open-market purchase on record since 2025. Sales in 1 of the 2 years since 2025.
Julie Larson-green reported 0 open-market purchases and 1 sale since 2025; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $128K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Sep 1, 2026, Julie Larson-green reported holding 185,101 shares of Health Catalyst (HCAT). At the last close of $2 on Nov 13, 2026, that is about $280K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Julie Larson-green reported 1 open-market sale worth $128K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Julie Larson-green has no open-market purchase on record since 2025. Sales in 1 of the 2 years since 2025.
In SEC filings since 2025: no open-market purchase is on record; the latest open-market sale is from 2025.
Health Catalyst (HCAT), from 2025 to 2025: 0 purchases and 1 sale.
Julie Larson-green reported 0 open-market purchases and 1 sale here, 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
